BARRIS PETER J

Average Profitability
<0.0001%
Insider Buys Quantity
21
Insider Buys Sum
$384.11M
Insider Sells Quantity
28
Insider Sells Sum
$165.73M

Insider Activity of BARRIS PETER J

The largest purchase of all time was on 2015-06-05 and amounted to 6542056 shares of Ardelyx, Inc. for $70M.

The largest sale of all time was on 2017-11-20 and amounted to 5641032 shares of Appian Corporation for $109.94M.

Biography of BARRIS PETER J

No biography is available at this moment.

2019-12-26SaleGroupon, Inc.
GRPN
director
420,248
0.0736%
$2.34$981,909-48.54%
2019-07-22PurchaseMirum Pharmaceuticals, Inc.
MIRM
10 percent owner
900,000
5.3814%
$15.00$13.5M+5.09%
2019-05-09PurchaseTrevi Therapeutics, Inc.
TRVI
10 percent owner
5M
34.6117%
$10.00$50M-42.9%
2019-05-07PurchaseRegulus Therapeutics Inc.
RGLS
10 percent owner
1.14M
6.1239%
$1.08$1.23M-40%
2018-09-07PurchaseAdaptimmune Therapeutics plc
ADAP
10 percent owner
30M
4.8721%
$1.67$50M-57.66%
2018-07-30PurchaseLiquidia Corporation
LQDA
10 percent owner
545,455
4.6996%
$11.00$6M+38.27%
2018-05-10SaleGlycoMimetics, Inc.
GLYC
10 percent owner
19,078
0.0446%
$17.81$339,779-26.95%
2018-03-27PurchaseAdaptimmune Therapeutics plc
ADAP
10 percent owner
12M
2.1988%
$1.92$23M-12.28%
2018-03-26PurchaseAdaptimmune Therapeutics plc
ADAP
10 percent owner
1.14M
0.2007%
$1.90$2.18M-14.01%
2018-03-23PurchaseAdaptimmune Therapeutics plc
ADAP
10 percent owner
588,180
0.1062%
$1.95$1.14M-12.52%
2018-03-22PurchaseAdaptimmune Therapeutics plc
ADAP
10 percent owner
1.74M
0.308%
$1.90$3.31M-12.12%
2018-03-21PurchaseAdaptimmune Therapeutics plc
ADAP
10 percent owner
209,688
0.0355%
$1.81$379,640-10.61%
2017-12-08SaleSenseonics Holdings, Inc.
SENS
10 percent owner
32,850
0.0283%
$2.59$85,200+30.96%
2017-12-07SaleSenseonics Holdings, Inc.
SENS
10 percent owner
12,100
0.0106%
$2.61$31,628+31.78%
2017-12-06SaleSenseonics Holdings, Inc.
SENS
10 percent owner
94,695
0.0817%
$2.64$249,995+28.79%
2017-11-27SaleAppian Corporation
APPN
10 percent owner
1.14M
2.1156%
$19.49$22.2M+42.78%
2017-11-20SaleAppian Corporation
APPN
10 percent owner
5.64M
11.2735%
$19.49$109.94M+53.66%
2017-10-10PurchaseRhythm Pharmaceuticals, Inc.
RYTM
10 percent owner
550,000
1.3734%
$17.00$9.35M+9.57%
2017-08-10SaleGroupon, Inc.
GRPN
director
562,718
0.1005%
$3.98$2.24M+17.5%
2017-08-09SaleGroupon, Inc.
GRPN
director
562,720
0.1002%
$3.93$2.21M+18.69%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.